Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma

Status Completed

Clinical Trial Summary

The goal of this clinical trial is to evaluate the safety and clinical outcomes of two-session catheter-directed sclerotherapy (CDS) with 96% ethanol in patients with endometrioma. The main question it aims to answer is: • Is two-session CDS with 96% ethanol safe and effective for treating endometrioma? Participants will: - Receive the first session CDS for endometrioma - Carry the catheter overnight and be monitored in the patient ward - Receive the second session CDS the next day

Clinical Trial Description

Catheter-directed sclerotherapy has been reported as an effective treatment for endometrioma. However, whether the sclerosing agent should be retained inside the endometrioma was controversial. To increase the contact between the sclerosing agent and the endometrioma wall, two-session catheter-directed sclerotherapy using 96% ethanol was attempted, and safety and clinical outcomes were assessed in patients with endometrioma. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06274086
Study type	Interventional
Source	Asan Medical Center
Contact
Status	Completed
Phase	N/A
Start date	June 1, 2020
Completion date	March 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01268930` - Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas	N/A
Completed	`NCT05323539` - Comparison of Thyroid Volumes in Patients With and Without Endometrioma	N/A
Recruiting	`NCT04178876` - Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( CLESS)	N/A
Completed	`NCT06421857` - Hemostatic Measures During Laparoscopic Cystectomy for Endometrioma	N/A
Recruiting	`NCT04151433` - Conservative Endometrioma Surgery	N/A
Completed	`NCT01942122` - DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis	Phase 2/Phase 3
Withdrawn	`NCT00999479` - Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation	N/A
Recruiting	`NCT03687398` - Genomic Maps of Endometrial Tissues of Patients With Endometriosis and Healthy Controls
Not yet recruiting	`NCT06377553` - PET/MRI for Evaluation of Endometriosis
Not yet recruiting	`NCT03788720` - Suture of the Ovary After Enucleation of Ovarian Endometrioma	N/A
Completed	`NCT01982526` - Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients
Recruiting	`NCT05962775` - Ethanol Sclerotherapy Prior to ART	N/A
Completed	`NCT03484546` - Optimum Menstrual Cycle Time for Endometrioma Excision
Completed	`NCT01808170` - Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve	N/A
Recruiting	`NCT05637073` - Effect of Management of the Endometrioma on Ovarian Reserve
Completed	`NCT06219044` - Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization	N/A
Recruiting	`NCT03620838` - Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
Terminated	`NCT03571776` - Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial	N/A
Enrolling by invitation	`NCT02472873` - Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas	N/A
Completed	`NCT04941833` - Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo	Phase 2/Phase 3